GSK Stock Today, December 8, 2025: Price, Buyback, CEO Change and 2026 Forecast
GSK shares closed at 1,805p in London and $48.41 in New York on 5 December, both slightly lower on the day but near 52-week highs. The company reported Q3 2025 sales of £8.5bn, up 7%, and raised its full-year guidance. GSK spent £1.1bn on buybacks through Q3 and declared a 16p quarterly dividend. The ADR is up about 40% over the past year.